Literature DB >> 32358089

Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data.

Michael Rullmann1, Anke McLeod2, Michel J Grothe3, Osama Sabri2, Henryk Barthel.   

Abstract

It was hypothesized that the brain β-amyloid buildup curve plateaus at an early symptomatic stage of Alzheimer disease (AD). Atrophy-related partial-volume effects (PVEs) degrade signal in hot-spot imaging techniques such as amyloid PET. The current study, a longitudinal analysis of amyloid-sensitive PET data, investigated the effect on the shape of the β-amyloid curve in AD when PVE correction (PVEC) is applied.
Methods: We analyzed baseline and 2-y follow-up data for 216 symptomatic individuals on the AD continuum (positive amyloid status) enrolled in the Alzheimer's Disease Neuroimaging Initiative (17 with AD dementia and 199 with mild cognitive impairment), including 18F-florbetapir PET, MRI, and Mini Mental State Examination scores. For PVEC, the modified Müller-Gärtner method was performed.
Results: Compared with non-PVE-corrected data, PVE-corrected data yielded significantly higher changes in regional and composite SUV ratio (SUVR) over time (P = 0.0002 for composite SUVRs). Longitudinal SUVR changes in relation to Mini Mental State Examination decreases showed a significantly higher slope for the regression line in the PVE-corrected than in the non-PVE-corrected PET data (F 1 = 7.1, P = 0.008).
Conclusion: These PVEC results indicate that the β-amyloid buildup curve does not plateau at an early symptomatic disease stage. A further evaluation of the impact of PVEC on the in vivo characterization of time-dependent AD pathology, including the reliable assessment and comparison of other amyloid tracers, is warranted.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PET; amyloid; longitudinal; partial-volume effect correction

Mesh:

Substances:

Year:  2020        PMID: 32358089      PMCID: PMC9364900          DOI: 10.2967/jnumed.119.238477

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   11.082


  38 in total

1.  A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.

Authors:  Miho Shidahara; Benjamin A Thomas; Nobuyuki Okamura; Masanobu Ibaraki; Keisuke Matsubara; Senri Oyama; Yoichi Ishikawa; Shoichi Watanuki; Ren Iwata; Shozo Furumoto; Manabu Tashiro; Kazuhiko Yanai; Kohsuke Gonda; Hiroshi Watabe
Journal:  Ann Nucl Med       Date:  2017-06-21       Impact factor: 2.668

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B.

Authors:  Meryl A Butters; William E Klunk; Chester A Mathis; Julie C Price; Scott K Ziolko; Jessica A Hoge; Nicholas D Tsopelas; Brian J Lopresti; Charles F Reynolds; Steven T DeKosky; Carolyn C Meltzer
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

4.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

5.  Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.

Authors:  Michael Rullmann; Juergen Dukart; Karl-Titus Hoffmann; Julia Luthardt; Solveig Tiepolt; Marianne Patt; Hermann-Josef Gertz; Matthias L Schroeter; John Seibyl; Walter J Schulz-Schaeffer; Osama Sabri; Henryk Barthel
Journal:  J Nucl Med       Date:  2015-11-05       Impact factor: 10.057

6.  Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.

Authors:  Andrew J Aschenbrenner; Brian A Gordon; Tammie L S Benzinger; John C Morris; Jason J Hassenstab
Journal:  Neurology       Date:  2018-08-01       Impact factor: 9.910

7.  Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.

Authors:  P M Doraiswamy; R A Sperling; K Johnson; E M Reiman; T Z Wong; M N Sabbagh; C H Sadowsky; A S Fleisher; A Carpenter; A D Joshi; M Lu; M Grundman; M A Mintun; D M Skovronsky; M J Pontecorvo
Journal:  Mol Psychiatry       Date:  2014-03-11       Impact factor: 15.992

8.  Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies.

Authors:  Yi Su; Shaney Flores; Guoqiao Wang; Russ C Hornbeck; Benjamin Speidel; Nelly Joseph-Mathurin; Andrei G Vlassenko; Brian A Gordon; Robert A Koeppe; William E Klunk; Clifford R Jack; Martin R Farlow; Stephen Salloway; Barbara J Snider; Sarah B Berman; Erik D Roberson; Jared Brosch; Ivonne Jimenez-Velazques; Christopher H van Dyck; Douglas Galasko; Shauna H Yuan; Suman Jayadev; Lawrence S Honig; Serge Gauthier; Ging-Yuek R Hsiung; Mario Masellis; William S Brooks; Michael Fulham; Roger Clarnette; Colin L Masters; David Wallon; Didier Hannequin; Bruno Dubois; Jeremie Pariente; Raquel Sanchez-Valle; Catherine Mummery; John M Ringman; Michel Bottlaender; Gregory Klein; Smiljana Milosavljevic-Ristic; Eric McDade; Chengjie Xiong; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Alzheimers Dement (Amst)       Date:  2019-02-22

9.  Contributions of imprecision in PET-MRI rigid registration to imprecision in amyloid PET SUVR measurements.

Authors:  Christopher G Schwarz; David T Jones; Jeffrey L Gunter; Val J Lowe; Prashanthi Vemuri; Matthew L Senjem; Ronald C Petersen; David S Knopman; Clifford R Jack
Journal:  Hum Brain Mapp       Date:  2017-04-22       Impact factor: 5.038

10.  Partial volume correction for PET quantification and its impact on brain network in Alzheimer's disease.

Authors:  Jiarui Yang; Chenhui Hu; Ning Guo; Joyita Dutta; Lucia M Vaina; Keith A Johnson; Jorge Sepulcre; Georges El Fakhri; Quanzheng Li
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

View more
  2 in total

1.  Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome.

Authors:  Sebastian Schuster; Leonie Beyer; Carla Palleis; Stefanie Harris; Julia Schmitt; Endy Weidinger; Catharina Prix; Kai Bötzel; Adrian Danek; Boris-Stephan Rauchmann; Sophia Stöcklein; Simon Lindner; Marcus Unterrainer; Nathalie L Albert; Lena M Mittlmeier; Christian Wetzel; Rainer Rupprecht; Axel Rominger; Peter Bartenstein; Robert Perneczky; Johannes Levin; Günter U Höglinger; Matthias Brendel; Franziska J Dekorsy
Journal:  Brain Sci       Date:  2022-01-31

2.  Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology.

Authors:  Adam Martersteck; Ivan Ayala; Daniel T Ohm; Callen Spencer; Christina Coventry; Sandra Weintraub; Eileen H Bigio; M -Marsel Mesulam; Changiz Geula; Emily Rogalski
Journal:  Acta Neuropathol Commun       Date:  2022-08-09       Impact factor: 7.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.